相关实验视频
Updated: Jul 21, 2025

12:46
Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
Published on: August 17, 2022
2.6K
免疫细胞在扩展性心肌病中的分子作用
Enping Wang1,2, Ruofan Zhou1,2, Tiange Li1,2
1Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.
Medicina (Kaunas, Lithuania)
|July 29, 2023
概括
扩张性心肌病 (DCM) 涉及免疫细胞在心力衰竭的进展. 了解免疫细胞的作用和免疫疗法为这种严重的心脏病提供了新的治疗途径.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 病理生理学 病理生理学
背景情况:
- 扩张性心肌病 (DCM) 是一种严重的心脏病,导致腔室扩张和左心室收缩受损.
- DCM是心力衰竭和心脏突然死亡的主要原因,需要心脏移植.
- DCM的病因不同,包括遗传,表观遗传,传染性,自身免疫因素和导电异常.
研究的目的:
- 审查了解DCM中免疫细胞分子机制的最新进展.
- 评估目前DCM免疫治疗方法的有效性和局限性.
- 在DCM管理中确定未来免疫治疗策略的潜在优化方法.
主要方法:
- 文献综述侧重于DCM中免疫细胞的分子机制.
- 对免疫疗法的有效性和DCM的挑战现有数据的分析.
- 综合当前的知识,提出未来的研究方向.
主要成果:
- 居民和招募的免疫细胞在DCM病原发生中起着关键作用,特别是在心肌纤维化和炎症中.
- 由免疫细胞主导的炎症过程与DCM预后密切相关.
- 目前的免疫疗法方法看起来很有前途,但有局限性需要解决.
结论:
- 免疫细胞参与是DCM发展和进展的核心.
- 针对免疫细胞的功能和调节,为DCM提供了一个有前途的治疗策略.
- 对优化免疫疗法的进一步研究对于改善DCM患者的治疗结果至关重要.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy I: Introduction and Classification
15
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12

